The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism

Published:2014-06-18 Issue:14 Volume:5 Page:5428-5438
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Pickhard Anja¹,Siegl Michael¹,Baumann Alexander¹,Huhn Maximilian¹,Wirth Markus¹,Reiter Rudolf²,Rudelius Martina³,Piontek Guido¹,Brockhoff Gero⁴

Affiliation:

1. Department of Otolaryngology Head and Neck Surgery, Technical University of Munich, Muenchen, Germany

2. Department of Otolaryngology Head and Neck Surgery, Section of Phoniatrics and Pedaudiology, University of Ulm, Ulm, Germany

3. Institute of Pathology, Julius-Maximilians-University and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany

4. Department of Gynecology and Obstetrics; University of Regensburg, Regensburg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines;Frontiers in Veterinary Science;2022-11-17

2. Gene polymorphisms and post‐treatment toxicity and treatment response in head and neck squamous cell carcinoma: A scoping review;Oral Science International;2022-09-16

3. Resistencia a los anticuerpos monoclonales anti-EGFR en el tratamiento del carcinoma de cabeza y cuello;Ars Pharmaceutica (Internet);2021-09-20

4. Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers;Frontiers in Oncology;2021-02-25

5. A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC);EBioMedicine;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3